|
KIAA1217 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.65409999977706E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03119999994572E-06 |
| Normal-vs-Stage2 |
2.03109999999951E-05 |
| Normal-vs-Stage3 |
4.824900E-04 |
| Normal-vs-Stage4 |
3.136000E-03 |
| Stage1-vs-Stage2 |
6.720200E-01 |
| Stage1-vs-Stage3 |
5.434200E-01 |
| Stage1-vs-Stage4 |
9.978400E-01 |
| Stage2-vs-Stage3 |
3.722200E-01 |
| Stage2-vs-Stage4 |
7.604200E-01 |
| Stage3-vs-Stage4 |
7.115200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88319999594455E-08 |
| Normal-vs-AfricanAmerican |
2.34639999999731E-05 |
| Normal-vs-Asian |
9.367600E-01 |
| Caucasian-vs-AfricanAmerican |
5.389200E-01 |
| Caucasian-vs-Asian |
1.280360E-02 |
| AfricanAmerican-vs-Asian |
4.390500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44789744030527E-11 |
| Normal-vs-Female |
9.500300E-03 |
| Male-vs-Female |
1.760720E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.85480000000671E-05 |
| Normal-vs-Extreme_Weight |
8.28040003231223E-09 |
| Normal-vs-Obese |
9.92149999999858E-05 |
| Normal-vs-Extreme_Obese |
1.56640999999791E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.433600E-01 |
| Normal_Weight-vs-Obese |
4.588200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.728400E-02 |
| Extreme_Weight-vs-Obese |
4.192100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.078200E-01 |
| Obese-vs-Extreme_Obese |
7.076300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.218850E-01 |
| Normal-vs-Age(41-60Yrs) |
8.31850000000411E-05 |
| Normal-vs-Age(61-80Yrs) |
1.11020004300855E-09 |
| Normal-vs-Age(81-100Yrs) |
4.29660000023091E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.641400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.279400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.504660E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.624800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.815200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.434790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.33889996048964E-09 |
| Normal-VS-Type2 PRCC |
2.66639998969254E-09 |
| Normal-VS-KIRP CIMP |
4.348200E-01 |
| Normal-VS-Unclassified PRCC |
1.536770E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.795800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.193840E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.873200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.538200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.790000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.785020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1424999946108E-08 |
| Normal-vs-N1 |
2.703200E-03 |
| Normal-vs-N2 |
6.318400E-02 |
| N0-vs-N1 |
7.236200E-02 |
| N0-vs-N2 |
5.491800E-01 |
| N1-vs-N2 |
7.915400E-01 |
|
|
